Mean cholesterol, triglyceride, HDL, LDL, VLDL, TB (total bilirubin), DB (direct bilirubin), GGT, SGPT, ALP, and SGOT values for the NAFLD severity groups (severe vs. moderate vs. mild) were as followed; (203.8 vs. 186.8 vs. 179.1; P<0.001), (161.2 vs. 147 vs. 118.1; P<0.001), (40.4 vs. 46.1 vs. 51.7; P<0.001), (131.9 vs. 117.7 vs. 113.2; P<0.001), (31.6 vs. 30.2 vs. 26.3; P<0.001), (1.01 vs. 0.92 vs. 0.75; P<0.001), (0.28 vs. 0.22 vs. 0.18; P<0.001), (84.4 vs. 37.3 vs. 19.5; P<0.001), (69.9 vs. 50.2 vs. 44.3; P<0.001), (121.2 vs. 95.2 vs. 80.7; P<0.001) and (55.4 vs. 41.1 vs. 37.5; P<0.001). The gene discussed is GOT1; the disease is metabolic dysfunction-associated steatotic liver disease.